Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.

about

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.

Item

http://www.wikidata.org/entity/Q47742744

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.

@en

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.

@nl

type

Item

label

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.

@en

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.

@nl

prefLabel

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.

@en

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.

@nl

P1476

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management

@en

P2093

Ali T Taher

http://www.w3.org/2001/XMLSchema#string

Ali Tarhini

http://www.w3.org/2001/XMLSchema#string

Antoine N Saliba

http://www.w3.org/2001/XMLSchema#string

Joseph Sleiman

http://www.w3.org/2001/XMLSchema#string

Rayan Bou-Fakhredin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

β-thalassemia intermedia: a clinical perspective

Anemia: progress in molecular mechanisms and therapies

Therapeutic genome editing: prospects and challenges

Vision and hearing during deferoxamine therapy

The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation

Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America.

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

Beta-thalassaemia intermedia: evaluation of endocrine and bone complications.

Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia

A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers.

P31

scholarly article

P356

10.3390/IJMS19010182

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maria Domenica Cappellini

P5008

ScienceSource

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29316681

http://www.w3.org/2001/XMLSchema#string

P921

thalassemia

P932

5796131

http://www.w3.org/2001/XMLSchema#string